To raise awareness about the challenges related to coverage policies, SWHR released the policy brief, "Issues Affecting Health Care Coverage and Access for Women with Autoimmune Diseases and Conditions." The brief is the first in a series of four.
Representatives Kathy Castor (D-FL), Brian Fitzpatrick (R-PA), and Lauren Underwood (D-IL) introduced H.R. 9487, the Advancing Safe Medications for Moms and Babies Act of 2022 on December 13, 2022.
The SWHR autoimmune policy agenda serves as a call to action for research, education, awareness, advocacy, clinical care, and coverage to support women impacted by autoimmune diseases and conditions.
The SWHR Alzheimer’s Policy Agenda was released in conjunction with Alzheimer’s Disease Awareness Month in November and serves as a resource for policymakers.
These new Policy Principles build upon SWHR's 2019 principles, now accounting for changes in the health care value assessment landscape that specifically impact women.
Congress passed a short-term continuing resolution (CR) to keep the government funded at current levels through December 16, 2022, providing lawmakers more time to reach a deal on fiscal year (FY) 2023 spending legislation.
At SWHR's September Policy Advisory Council meeting, the Senior Legislative Assistant in the Office of Congresswoman Lauren Underwood (IL-14) and Executive Director of the Coalition for Health Funding shared updates.
Narcolepsy can affect all aspects of a person’s life, including work life. Know management and wellness tips for narcolepsy in the workplace.
Elizabeth Sinclair Hancq, Director of Research at the Treatment Advocacy Center, discusses the health care burden of severe mental illness in women.
Prenatal genetic screening can be a helpful tool for future parents to make informed decisions about their health care. SWHR spoke with two experts at the National Society of Genetic Counselors (NSGC) about genetic screening.